NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
N/A (NSE: NIF100BEES)
NIF100BEES Technical Analysis
2
As on 27th Mar 2025 NIF100BEES SHARE Price closed @ 253.23 and we RECOMMEND Sell for LONG-TERM with Stoploss of 259.21 & Strong Buy for SHORT-TERM with Stoploss of 247.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NIF100BEESSHARE Price
Open | 252.89 | Change | Price | % |
High | 255.00 | 1 Day | 0.67 | 0.27 |
Low | 251.02 | 1 Week | 3.56 | 1.43 |
Close | 253.23 | 1 Month | 11.52 | 4.77 |
Volume | 30066 | 1 Year | 15.65 | 6.59 |
52 Week High 272.89 | 52 Week Low 174.91 |
NSE N/A Most Active Stocks
NSE N/A Top Gainers Stocks
MBLINFRA | 41.40 | 20.00% |
JINDWORLD | 66.30 | 19.98% |
AURIONPRO | 1649.65 | 19.80% |
BFUTILITIE | 765.35 | 18.52% |
STCINDIA | 136.45 | 15.92% |
CYIENTDLM | 445.95 | 15.08% |
GARFIBRES | 944.65 | 15.02% |
DRCSYSTEMS | 25.89 | 14.41% |
MAHSCOOTER | 11724.40 | 13.95% |
BEML | 3140.40 | 13.77% |
NSE N/A Top Losers Stocks
SANGINITA | 8.79 | -15.97% |
CGCL | 164.90 | -15.38% |
NDLVENTURE | 53.08 | -13.24% |
GENCON | 23.94 | -12.82% |
SMLT | 99.10 | -10.28% |
SMLT | 99.10 | -10.28% |
KESORAMIND | 4.42 | -10.16% |
BINANIIND | 9.19 | -10.08% |
SINDHUTRAD | 16.19 | -10.01% |
XELPMOC | 83.46 | -9.88% |
NIF100BEES Daily Charts |
NIF100BEES Intraday Charts |
Whats New @ Bazaartrend |
NIF100BEES Free Analysis |
|
NIF100BEES Important Levels Intraday
RESISTANCE | 260.90 |
RESISTANCE | 258.44 |
RESISTANCE | 256.92 |
RESISTANCE | 255.40 |
SUPPORT | 251.06 |
SUPPORT | 249.54 |
SUPPORT | 248.02 |
SUPPORT | 245.56 |
NIF100BEES Target March 2025
4th UP Target | 309.81 |
3rd UP Target | 291.54 |
2nd UP Target | 280.24 |
1st UP Target | 268.95 |
1st DOWN Target | 236.71 |
2nd DOWN Target | 225.42 |
3rd DOWN Target | 214.12 |
4th DOWN Target | 195.85 |
NIF100BEES Weekly Target
4th UP Target | 289.11 |
3rd UP Target | 277.06 |
2nd UP Target | 269.61 |
1st UP Target | 262.16 |
1st DOWN Target | 240.90 |
2nd DOWN Target | 233.45 |
3rd DOWN Target | 226.00 |
4th DOWN Target | 213.95 |
NIF100BEES Target2025
4th UP Target | 439.02 |
3rd UP Target | 380.94 |
2nd UP Target | 345.04 |
1st UP Target | 309.14 |
1st DOWN Target | 206.7 |
2nd DOWN Target | 170.8 |
3rd DOWN Target | 134.9 |
4th DOWN Target | 76.82 |
N/A ( NSE N/A Symbol : NIF100BEES )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
NIF100BEES Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
NIF100BEES Other Details
Segment | N/A | |
Market Capital | N/A | |
Sector | N/A | |
Industry | N/A | |
Offical website | > echo $website ; ?> |
NIF100BEES Address
![]() |
N/A |
NIF100BEES Latest News
NIF100BEES Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service